RBC Capital lifts Axsome stock target to $143, sees launch potential
RBC Capital Markets analyst Leonid Timashev increased the price target for Axsome Therapeutics (NASDAQ:AXSM) to $143 from $139, while keeping an Outperform rating on the stock. According to ...
RBC Capital sees Software stocks gaining from GenAI tech
RBC Capital Markets highlighted a group of software companies poised to benefit from the latest advancements in generative artificial intelligence (GenAI), particularly through innovations like ...
Indiatimes22h
Nifty Capital Market
What was the previous day's closing value of Nifty Capital Market? The previous day's closing value of Nifty Capital Market was 3439.1. As of today, the current value of Nifty Capital Market stands at ...
Bloomberg L.P.22h
China Tower Corp Ltd
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Business Standard8h
Veedol Corporation Share Price
Motilal Oswal Nifty Microcap 250 Index Fund-Reg (G) 2.38 14,468 0.12 Motilal Oswal Nifty Microcap 250 Index Fund-Dir (G) 2.38 14,468 0.12 Groww Nifty Total Market Index Fund-Regular (G) 0.01 79 0.00 ...
cnbctv189h
Share Market Live
Brokerage firm Kotak Institutional Equities has initiated coverage on Swiggy Ltd. with a ‘Buy’ rating and a price target of ₹500. Kotak’s price target implies a potential upside of 15% on Swiggy from ...